Security key
45258H106
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 52,769,253
- Total 13F shares
- 298,959
- Share change
- +115,574
- Total reported value
- $406,000
- Price per share
- $1.36
- Number of holders
- 7
- Value change
- +$156,569
- Number of buys
- 6
- Number of sells
- 1
Report period
Q3 2022
Institutions
7
Top holders
7
IMMX full security history
Newer quarter: Q4 2022
Previous quarter: Q2 2022
Immix Biopharma, Inc. SEC filings
Immix Biopharma, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 45258H106
Recent filing periods:
Top shareholders of IMMX - Immix Biopharma, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Vladimir P. Torchilin |
3/4/5
|
Scientific Co-Founder |
—
class O/S missing
|
905,200
|
$4,230,905 | — | 20 Dec 2021 | |
| Sean Senn |
3/4/5
|
Under 10% owner |
—
class O/S missing
|
899,800
|
$4,205,665 | — | 14 Jul 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.14%
|
73,333
|
$190,000 | — | 30 Jun 2022 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.1%
|
50,905
|
$132,000 | — | 30 Jun 2022 | |
| STATE STREET CORP |
13F
|
Company |
0.07%
|
38,560
|
$100,000 | — | 30 Jun 2022 | |
| InterOcean Capital Group, LLC |
13F
|
Company |
0.03%
|
15,900
|
$41,000 | — | 30 Jun 2022 | |
| UBS Group AG |
13F
|
Company |
0.01%
|
4,337
|
$11,000 | — | 30 Jun 2022 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
350
|
$1,000 | — | 30 Jun 2022 |
Institutional Holders of Immix Biopharma, Inc. - Common Stock (IMMX) as of Q3 2022
As of 30 Sep 2022,
Immix Biopharma, Inc. - Common Stock (IMMX) was held by
7 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
298,959 shares.
The largest 7 holders included
VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, RENAISSANCE TECHNOLOGIES LLC, NORTHERN TRUST CORP, InterOcean Capital Group, LLC, and UBS Group AG.
This page lists
7
institutional shareholders reporting positions in this security
for the Q3 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2022 vs Q2 2022 Across Filers
Q2 2022 holders
6
Q3 2022 holders
7
Holder diff
1
| Investor | Q2 2022 Shares | Q3 2022 Shares | Share Diff | Share Chg % | Q2 2022 Value $ | Q3 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.